Journals / Solunum Hastalıkları / 2002 / Cilt: 13 - Sayı: 4

Serum immunoglobulin levels of chronic obstructive pulmonary disease cases and healthy current smokers

Kronik obstrüktif akciğer hastalığı olan ve sigara içen sağlıklı olgularda serum immünglobulin düzeyleri

Pages
246–255
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We observed that smoking reduced serum IgG, lgC2 and IgM levels but there was no relation between number of exacerbations in COPD cases and serum IgC and lgG2 levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to investigate the relation between recurrent pulmonary infections and IgG and subclasses levels and to determine serum Ig levels in current smokers with chronic obstructive pulmonary disease (COPD) and asymptomatic smokers.
📊
Key Findings & Data:Three groups were included in the study; current smoker with COPD (n= 30), asymptomatic smokers (n= 15) and never smokers (n=15).
💡
Conclusion & Impact:We observed that smoking reduced serum IgG, lgC2 and IgM levels but there was no relation between number of exacerbations in COPD cases and serum IgC and lgG2 levels.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:IgM · IgG · IgA

Abstract

We aimed to investigate the relation between recurrent pulmonary infections and IgG and subclasses levels and to determine serum Ig levels in current smokers with chronic obstructive pulmonary disease (COPD) and asymptomatic smokers. Three groups were included in the study; current smoker with COPD (n= 30), asymptomatic smokers (n= 15) and never smokers (n=15). Serum IgG, IgA, IgM and IgG subclasses were assessed in cases who have inclusion criteria. Serum IgG levels were significantly lower in both COPD cases and asymptomatic smokers than never smokers (respectively; p= 0.001, p= 0.002). Similarly lgG2 level was significantly lower in both COPD cases and asymptomatic smokersthan never smokers (p< 0.001). Serum IgA levels were significantly higher in COPD cases than asymptomatic smokers (p= 0.002). Serum IgM levels were significantly lower in COPD cases than never smokers (p< 0.001). When COPD cases were divided in two groups depend on number of exacerbations (number of exacerbations $\leq$ 4 and > 4 in recent 2 years) there was no difference between IgC and lgG2 levels. We observed that smoking reduced serum IgG, lgC2 and IgM levels but there was no relation between number of exacerbations in COPD cases and serum IgC and lgG2 levels.

Özet

Çalışmamızda halen sigara içmeye devam eden kronik obstrüktif akciğer hastalığı (KOAH) olan olgularda, asemptomatik sigara içicilerde serum İmmünglobulin (lg) düzeylerinin belirlenmesi ve tekrarlayan solunum yolu infeksiyonlarının, IgG ve alt gruplarının seviyeleri ile ilişkisinin araştırılması amaçlandı. Sigara içen KOAH (n= 30)'lılar, asemptomatik sigara içiciler (n= 15) ve hiç sigara içmemiş (n= 15) olgulardan oluşan 3 grup oluşturuldu. Çalışmaya dahil edilme kriterlerine uyan olgularda serum IgG, IgA, IgM ve IgG subtip düzeyleri ölçüldü. IgG düzeyi hem KOAH'lı hem de asemptomatik içicilerde hiç sigara içmeyen olgulara göre anlamlı ölçüde düşük bulundu (sırasıyla; p= 0.001, p= 0.002). lgG2 düzeyi de KOAH'lı ve asemptomatik içicilerde hiç sigara içmeyen olgulara göre anlamlı derecede düşüktü (p 4 olanlar) IgG ve lgG2 düzeyleri arasında fark saptanmadı. Sigara içiminin serum IgG, lgG2 ve IgM düzeylerini azalttığı, ancak KOAH'lı olgularda atak sayısı ile IgG ve lgG2 düzeyleri arasında ilişki olmadığı gözlendi.

🔖

Cite This Article

DEVECİ, F., TURGUT, T., AKBULUT, H. H., KIRKIL, G., MUZ, M. H. (2002). Serum immunoglobulin levels of chronic obstructive pulmonary disease cases and healthy current smokers. Solunum Hastalıkları, Cilt: 13 - Sayı: 4, 246–255. https://ajindex.com/articles/318663

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Mili F, Flanders WD, Boring JR et al. The association of race, cigarette smoking, and smoking cessation to measures of the immune system in middle aged men. Clin Immunol Immunopathol 1991;59:187-200
  2. McMillan SA, Douglas jP, Archbold GP et al. Effect of low to moderate levels of smoking and alcohol consumption on serum immunoglobulin concentrations, j Clin Pathol 1997;50:819-22
  3. MarcyTW, Mrril WW. Cigarette smoking and respiratory tract infection. Clin Chest Med 1987;8:381 -91
  4. Qvarfordt I, Riise GC, Larsson S et al. Immunological findings in blood and btonchoalveolar lavage fluid in chronic bronchitis patients with recurrent infectious exacerbations. Eur Respir J 1998;11:46-54
  5. Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO workshop report. April 2001, publication number 2701
  6. Riise GC,.Larsson S, Larsson P et al. The intrabronchial microbial flora in chronic bronchitis: A target for N-acetylcysteine therapy. Eur Respir J 1994;7:94-101
  7. Official Statement of the American Thoracic Society. Standarts for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 1 36:225-44
  8. Qvarfordt I, Riise GC, Andersson BA, Larsson S. IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations. Thorax 2001;56:445-9
  9. Nielsen H, Bonde J. Association of defective monocyte chemotaxis with recurrent acute exacerbations in chronic obstructive lung disease. Eur j Respir Dis 1986;68: 200-6
  10. Fietta A, Bersani C, De Rose V et al. Evaluation of systemic host defense mechanisms in chronic bronchitis. Respiration 1988;53:37-43
  11. Popa V, Kim MD, Heiner DC. IgG deficiency in adults with recurrent respiratory infections. Ann Allergy 1993; 70:418-23
  12. Stanley Pj, Corbo G, Cole Pj. Serum IgG subclasses in chronic and recurrent respiratory infections. Clin Exp Immunol 1984;58:703-8
  13. O'Keefe S, Gzel A, Drury R et al. Immunoglobulin G subclasses and spirometry in patients with chronic obst¬ructive pulmonary disease. Eur Respir J 1991;4:932-6
  14. Oxelius VA. Chronic infections in a family with hereditary deficiency of lgG2 and IgG^ Clin Exp Immunol 1974;17:19-27
  15. Gerard JM; Heiner DC, Ko CG, Mirik ] et al. Immunoglobulin levels in smokers and nonsmokers. Ann Allergy 1980;44:261-2
  16. Bjorklander ], Bake B, Oxelius VA, Hanson LA. Impaired lung function in patients with IgA deficiency and low levels of lgG2 or lgG3. N Engl j Med 1985;31 3:720-4. 17.